Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 5, 2026 · Filed Nov 9, 2026
A major shareholder of Nextcure paid $5.2K out of pocket for Nextcure shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$5,222
Shares × reported transaction price
<$25K
+0.1%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 1 month
Confirmed open-market purchases by the same insider in the available history
No
Compared with 16 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
91 days after results of Aug 6, 2026, 5 days before results of Nov 10, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $5.12 on Nov 5, 2026, 220% above its 52-week low and 64% below its high, after a 3% drop over the previous 30 trading days
52-week range $1.60 (Jun 30, 2026) to $14.27 (Feb 19, 2026), 28% of the way up, from 251 adjusted closes. 30 trading days earlier: $5.28 on Sep 24, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Traded 5 days before NXTC reported its results (Nov 10, 2026)
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
Insider buying
Traded Nov 11 · filed 2 days later
A major shareholder of Nextcure paid $63K out of pocket for Nextcure shares.
Insider buying
4 days before resultsTraded Nov 6 · filed 3 days later
A major shareholder of Nextcure paid $19K out of pocket for Nextcure shares.
Insider buying
3 days before an 8-KTraded Oct 23 · filed 4 days later
A major shareholder of Nextcure paid $27K out of pocket for Nextcure shares.
ADAR1 Capital Management, LLC, 10% owner's past purchases, 90 days after disclosure: 9 buys, median +2.3 pts vs S&P 500, beat it 6 of 9 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.